{"id":"https://openalex.org/W4200355178","doi":"https://doi.org/10.1080/14756366.2021.2015344","title":"2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights","display_name":"2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights","publication_year":2021,"publication_date":"2021-12-20","ids":{"openalex":"https://openalex.org/W4200355178","doi":"https://doi.org/10.1080/14756366.2021.2015344","pmid":"https://pubmed.ncbi.nlm.nih.gov/34923887","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8725837"},"language":"en","primary_location":{"id":"doi:10.1080/14756366.2021.2015344","doi":"https://doi.org/10.1080/14756366.2021.2015344","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14756366.2021.2015344","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.2015344?needAccess=true","source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.2015344?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057414292","display_name":"Mostafa M. Elbadawi","orcid":"https://orcid.org/0000-0002-9073-4176","observed_orcids":["https://orcid.org/0000-0002-9073-4176"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]},{"id":"https://openalex.org/I130309236","display_name":"Kafrelsheikh University","ror":"https://ror.org/04a97mm30","country_code":"EG","type":"education","lineage":["https://openalex.org/I130309236"]}],"countries":["EG","JP"],"is_corresponding":true,"raw_author_name":"Mostafa M. Elbadawi","raw_affiliation_strings":["Department of Chemistry, Graduate School of Science, Hiroshima University","Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University","Department of Chemistry, Graduate School of Science, Hiroshima University, Hiroshima, Japan","Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Graduate School of Science, Hiroshima University","institution_ids":["https://openalex.org/I113306721"]},{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University","institution_ids":["https://openalex.org/I130309236"]},{"raw_affiliation_string":"Department of Chemistry, Graduate School of Science, Hiroshima University, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]},{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt","institution_ids":["https://openalex.org/I130309236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070924066","display_name":"Wagdy Mohamed Eldehna","orcid":"https://orcid.org/0000-0001-6996-4017","observed_orcids":["https://orcid.org/0000-0001-6996-4017"]},"institutions":[{"id":"https://openalex.org/I130309236","display_name":"Kafrelsheikh University","ror":"https://ror.org/04a97mm30","country_code":"EG","type":"education","lineage":["https://openalex.org/I130309236"]}],"countries":["EG"],"is_corresponding":true,"raw_author_name":"Wagdy M. Eldehna","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University","Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University","institution_ids":["https://openalex.org/I130309236"]},{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt","institution_ids":["https://openalex.org/I130309236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061598575","display_name":"Amer Ali Abd El\u2010Hafeez","orcid":"https://orcid.org/0000-0002-4822-6581","observed_orcids":["https://orcid.org/0000-0002-4822-6581"]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]},{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["EG","US"],"is_corresponding":false,"raw_author_name":"Amer Ali Abd El-Hafeez","raw_affiliation_strings":["Department of Cellular and Molecular Medicine, University of California San Diego","Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University","Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA","Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular and Molecular Medicine, University of California San Diego","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University","institution_ids":["https://openalex.org/I145487455"]},{"raw_affiliation_string":"Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt","institution_ids":["https://openalex.org/I145487455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010261857","display_name":"Warda R. Somaa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130309236","display_name":"Kafrelsheikh University","ror":"https://ror.org/04a97mm30","country_code":"EG","type":"education","lineage":["https://openalex.org/I130309236"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Warda R. Somaa","raw_affiliation_strings":["Faculty of Pharmacy, Kafrelsheikh University","Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Kafrelsheikh University","institution_ids":["https://openalex.org/I130309236"]},{"raw_affiliation_string":"Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt","institution_ids":["https://openalex.org/I130309236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029330727","display_name":"Amgad Albohy","orcid":"https://orcid.org/0000-0003-3021-8767","observed_orcids":["https://orcid.org/0000-0003-3021-8767"]},"institutions":[{"id":"https://openalex.org/I154023281","display_name":"British University in Egypt","ror":"https://ror.org/0066fxv63","country_code":"EG","type":"education","lineage":["https://openalex.org/I154023281"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Amgad Albohy","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt (BUE)","Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt (BUE), Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt (BUE)","institution_ids":["https://openalex.org/I154023281"]},{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt (BUE), Cairo, Egypt","institution_ids":["https://openalex.org/I154023281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061206239","display_name":"Sara T. Al\u2010Rashood","orcid":"https://orcid.org/0000-0002-7785-4229","observed_orcids":["https://orcid.org/0000-0002-7785-4229"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Sara T. Al-Rashood","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University","Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University","institution_ids":["https://openalex.org/I28022161"]},{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061210045","display_name":"Keli Agama","orcid":"https://orcid.org/0000-0002-0505-8645","observed_orcids":["https://orcid.org/0000-0002-0505-8645"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keli K. Agama","raw_affiliation_strings":["Developmental Therapeutics Branch, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH","Developmental Therapeutics Branch, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Branch, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"Developmental Therapeutics Branch, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074335644","display_name":"Eslam B. Elkaeed","orcid":"https://orcid.org/0000-0002-2546-8035","observed_orcids":["https://orcid.org/0000-0002-2546-8035"]},"institutions":[{"id":"https://openalex.org/I4391767729","display_name":"Almaarefa University","ror":"https://ror.org/00s3s5518","country_code":"SA","type":"education","lineage":["https://openalex.org/I4391767729"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Eslam B. Elkaeed","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University","Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University","institution_ids":["https://openalex.org/I4391767729"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh, Saudi Arabia","institution_ids":["https://openalex.org/I4391767729"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013498569","display_name":"Pradipta Ghosh","orcid":"https://orcid.org/0000-0002-8917-3201","observed_orcids":["https://orcid.org/0000-0002-8917-3201"]},"institutions":[{"id":"https://openalex.org/I2799886695","display_name":"Veterans Health Administration","ror":"https://ror.org/05eq41471","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695"]},{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pradipta Ghosh","raw_affiliation_strings":["Department of Cellular and Molecular Medicine, University of California San Diego","Department of Medicine, University of California San Diego","Moores Comprehensive Cancer Center, University of California San Diego","Veterans Affairs Medical Center","Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA","Department of Medicine, University of California San Diego, La Jolla, CA, USA","Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, CA, USA","Veterans Affairs Medical Center, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular and Molecular Medicine, University of California San Diego","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Department of Medicine, University of California San Diego","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Moores Comprehensive Cancer Center, University of California San Diego","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Veterans Affairs Medical Center","institution_ids":["https://openalex.org/I2799886695"]},{"raw_affiliation_string":"Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Department of Medicine, University of California San Diego, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]},{"raw_affiliation_string":"Veterans Affairs Medical Center, La Jolla, CA, USA","institution_ids":["https://openalex.org/I2799886695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042114293","display_name":"Yves G. Pommier","orcid":"https://orcid.org/0000-0002-3108-0758","observed_orcids":["https://orcid.org/0000-0002-3108-0758"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yves Pommier","raw_affiliation_strings":["Developmental Therapeutics Branch, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH","Developmental Therapeutics Branch, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Branch, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"Developmental Therapeutics Branch, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087548495","display_name":"Manabu Abe","orcid":"https://orcid.org/0000-0002-2013-4394","observed_orcids":["https://orcid.org/0000-0002-2013-4394"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Manabu Abe","raw_affiliation_strings":["Department of Chemistry, Graduate School of Science, Hiroshima University","Department of Chemistry, Graduate School of Science, Hiroshima University, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Graduate School of Science, Hiroshima University","institution_ids":["https://openalex.org/I113306721"]},{"raw_affiliation_string":"Department of Chemistry, Graduate School of Science, Hiroshima University, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5057414292","https://openalex.org/A5070924066","https://openalex.org/A5087548495"],"corresponding_institution_ids":["https://openalex.org/I113306721","https://openalex.org/I130309236"],"apc_list":{"value":1880,"currency":"GBP","value_usd":2306},"apc_paid":{"value":1880,"currency":"GBP","value_usd":2306},"fwci":2.4907,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.89822446,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"37","issue":"1","first_page":"355","last_page":"378"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.6420999765396118,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.6420999765396118,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.28859999775886536,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.016100000590085983,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/2-arylquinolines","display_name":"2-arylquinolines","score":1.0},{"id":"https://openalex.org/keywords/egfr-kinase-inhibition","display_name":"EGFR kinase inhibition","score":0.6869999766349792},{"id":"https://openalex.org/keywords/focal-adhesion-kinase-inhibition","display_name":"focal adhesion kinase inhibition","score":0.9160000085830688},{"id":"https://openalex.org/keywords/dual-kinase-inhibitors","display_name":"dual kinase inhibitors","score":0.9269999861717224},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.9660000205039978},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.8999999761581421},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8560000061988831},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.7889999747276306},{"id":"https://openalex.org/keywords/dld-1-cells","display_name":"DLD-1 cells","score":0.8730000257492065},{"id":"https://openalex.org/keywords/hct116-cells","display_name":"HCT116 cells","score":0.9980000257492065},{"id":"https://openalex.org/keywords/molecular-modeling","display_name":"molecular modeling","score":0.5249999761581421},{"id":"https://openalex.org/keywords/quinoline-synthesis","display_name":"quinoline synthesis","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6683496832847595},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5586371421813965},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.5333319306373596},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5027728080749512},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4445628821849823},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4338943362236023},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4267582893371582},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3075490891933441},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2589987814426422},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.2037392258644104},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19054436683654785},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1861843466758728},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10509845614433289}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051417","descriptor_name":"Focal Adhesion Kinase 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051417","descriptor_name":"Focal Adhesion Kinase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1080/14756366.2021.2015344","doi":"https://doi.org/10.1080/14756366.2021.2015344","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14756366.2021.2015344","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.2015344?needAccess=true","source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:34923887","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34923887","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of enzyme inhibition and medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8725837","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8725837/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Enzyme Inhib Med Chem","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:b6980b7f5e534e5d98a5b57086664c83","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b6980b7f5e534e5d98a5b57086664c83","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 37, Iss 1, Pp 355-378 (2022)","raw_type":"article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt5t45352m","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/5t45352m","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry, vol 37, iss 1","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/17294191","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/2-Arylquinolines_as_novel_anticancer_agents_with_dual_EGFR_FAK_kinase_inhibitory_activity_synthesis_biological_evaluation_and_molecular_modelling_insights/17294191","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"doi:10.6084/m9.figshare.17294191.v1","doi":"https://doi.org/10.6084/m9.figshare.17294191.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.17294191.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1080/14756366.2021.2015344","doi":"https://doi.org/10.1080/14756366.2021.2015344","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14756366.2021.2015344","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.2015344?needAccess=true","source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3317154022","display_name":"DNA Topoisomerases as Target of Action of Anticancer Drugs","funder_award_id":"Z01BC006161","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6061748452","display_name":"Spatial Regulation of RGS and G Protein Signaling","funder_award_id":"R01CA100768","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7803089438","display_name":"Integrators of Metastatic Potential","funder_award_id":"R01CA238042","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000863933","display_name":"UCSD Cancer Center Training Program in Drug Development","funder_award_id":"T32CA121938","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G968326412","display_name":"Modulation of G proteins by Growth Factors","funder_award_id":"R01CA160911","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200355178.pdf","grobid_xml":"https://content.openalex.org/works/W4200355178.grobid-xml"},"referenced_works_count":59,"referenced_works":["https://openalex.org/W1031578623","https://openalex.org/W1608710587","https://openalex.org/W1887624773","https://openalex.org/W1911947704","https://openalex.org/W1964273180","https://openalex.org/W1985329580","https://openalex.org/W1988480703","https://openalex.org/W1994928998","https://openalex.org/W2014014132","https://openalex.org/W2028046413","https://openalex.org/W2041190145","https://openalex.org/W2041791898","https://openalex.org/W2041849614","https://openalex.org/W2048008261","https://openalex.org/W2050156776","https://openalex.org/W2057477511","https://openalex.org/W2060079863","https://openalex.org/W2067013768","https://openalex.org/W2067174909","https://openalex.org/W2081693079","https://openalex.org/W2092326879","https://openalex.org/W2109154308","https://openalex.org/W2128572087","https://openalex.org/W2134967712","https://openalex.org/W2156690451","https://openalex.org/W2296264213","https://openalex.org/W2310034942","https://openalex.org/W2337777157","https://openalex.org/W2560995823","https://openalex.org/W2725627050","https://openalex.org/W2766690104","https://openalex.org/W2772624448","https://openalex.org/W2802776187","https://openalex.org/W2804822363","https://openalex.org/W2809674728","https://openalex.org/W2889646458","https://openalex.org/W2890790252","https://openalex.org/W2900965797","https://openalex.org/W2943993066","https://openalex.org/W2951663696","https://openalex.org/W2954297401","https://openalex.org/W2982496306","https://openalex.org/W3011914182","https://openalex.org/W3032953040","https://openalex.org/W3042678060","https://openalex.org/W3048302770","https://openalex.org/W3096007007","https://openalex.org/W3096399688","https://openalex.org/W3110157922","https://openalex.org/W3113458973","https://openalex.org/W3120498776","https://openalex.org/W3121051418","https://openalex.org/W3126691344","https://openalex.org/W3127281565","https://openalex.org/W3127458633","https://openalex.org/W3128646645","https://openalex.org/W3137382409","https://openalex.org/W3138032798","https://openalex.org/W4233710528"],"related_works":["https://openalex.org/W2500082357","https://openalex.org/W4408481017","https://openalex.org/W2776137688","https://openalex.org/W1185762171","https://openalex.org/W4220812349","https://openalex.org/W4306736946","https://openalex.org/W2852377488","https://openalex.org/W2805555742","https://openalex.org/W4294123881","https://openalex.org/W4401728488"],"abstract_inverted_index":{"In":[0],"this":[1,35],"study,":[2,36],"different":[3],"assortments":[4],"of":[5,19],"2-arylquinolines":[6],"and":[7,42,58,84,90,103,113,126],"2,6-diarylquinolines":[8],"have":[9,14],"been":[10],"developed.":[11],"Recently,":[12],"we":[13,37],"developed":[15],"a":[16],"new":[17],"series":[18],"6,7-dimethoxy-4-alkoxy-2-arylquinolines":[20],"as":[21],"Topoisomerase":[22],"I":[23],"(TOP1)":[24],"inhibitors":[25,97],"with":[26,149],"potent":[27,50,95,150],"anticancer":[28,41],"activity.":[29],"Utilising":[30],"the":[31,93,116,137,145],"SAR":[32],"outputs":[33],"from":[34],"tried":[38],"to":[39,69,135],"enhance":[40],"TOP1":[43,63],"inhibitory":[44,80],"activities.":[45],"Though":[46],"target":[47],"quinolines":[48,108,148],"demonstrated":[49],"antiproliferative":[51],"effect,":[52],"specifically":[53],"against":[54,74,82],"colorectal":[55],"cancer":[56],"DLD-1":[57],"HCT-116,":[59],"they":[60],"showed":[61],"weak":[62],"inhibition":[64,119],"which":[65],"may":[66],"be":[67],"attributable":[68],"their":[70,78],"non-coplanarity.":[71],"Thereafter,":[72],"screening":[73],"kinase":[75],"panel":[76],"revealed":[77],"dual":[79,152],"activity":[81],"EGFR":[83,96],"FAK.":[85],"Quinolines":[86],"6f,":[87,109],"6h,":[88,110],"6i,":[89,111],"20f":[91,114],"were":[92],"most":[94],"(IC50s":[98,120],"=":[99,121],"25.39,":[100],"20.15,":[101],"22.36,":[102],"24.81":[104],"nM,":[105,128],"respectively).":[106,129],"Meanwhile,":[107],"16d,":[112],"exerted":[115],"best":[117],"FAK":[118],"22.68,":[122],"14.25,":[123],"18.36,":[124],"17.36,":[125],"15.36":[127],"Finally,":[130],"molecular":[131],"modelling":[132],"was":[133],"employed":[134],"justify":[136],"promising":[138],"EGFR/FAK":[139,151],"inhibition.":[140,153],"The":[141],"study":[142],"outcomes":[143],"afforded":[144],"first":[146],"reported":[147]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-12-31T00:00:00"}